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Purpose: Prior investigations of magnetic resonance imaging (MRI) biomarkers of cartilage loss in knee
osteoarthritis (OA) suggest that trials of interventions which affect this biomarker with adequate
statistical power would require large clinical studies of 1e2 years duration. We hypothesized that
smaller, shorter duration, “Proof of Concept” (PoC) studies might be achievable by: (1) selecting a pop-
ulation at high risk of rapid medial tibio-femoral (TF) progression, in conjunction with; (2) high-ﬁeld MRI
(3 T), and; (3) using advanced image analysis. The primary outcome was the cartilage thickness in the
central medial femur.
Methods: Multi-centre, non-randomized, observational cohort study at four sites in the US. Eligible
participants were females with knee pain, a body mass index (BMI) 25 kg/m2, symptomatic radio-
graphic evidence of medial TF OA, and varus mal-alignment. The 29 participants had a mean age of 62
years, mean BMI of 36 kg/m2, with eight index knees graded as KellgreneLawrence (K&L)¼ 2 and 21 as
K&L¼ 3. Eligible participants had four MRI scans of one knee: two MRIs (1 week apart) were acquired as
a baseline with follow-up MRI at 3 and 6 months. A trained operator, blind to time-point but not subject,
manually segmented the cartilage from the Dual Echo Steady State water excitation MR images.
Anatomically corresponding regions of interest were identiﬁed on each image by using a three-
dimensional statistical shape model of the endosteal bone surface, and the cartilage thickness (with areas
denuded of cartilage included as having zero thickness e ThCtAB) within each region was calculated. The
percentage change from baseline at 3 and 6 months was assessed using a log-scale analysis of variance
(ANOVA) model including baseline as a covariate. The primary outcome was the change in cartilage
thickness within the aspect of central medial femoral condyle exposed within the meniscal window (w)
during articulation, neglecting cartilage edges [nuclear (n)] (nwcMF$ThCtAB), with changes in other
regions considered as secondary endpoints.
Results: Anatomical mal-alignment ranged from 1.9 to 6.3, with mean 0.9. With one exception, no
changes in ThCtAB were detected at the 5% level for any of the regions of interest on the TF joint at 3 or 6
months of follow-up. The change in the primary variable (nwcMF$ThCtAB) from (mean) baseline at 3
months from the log-scale ANOVA model was 2.1% [95% conﬁdence interval (CI) (4.4%, þ0.2%)]. The
change over 6 months was 0.0% [95% CI (2.7%, þ2.8%)]. The 95% CI for the change from baseline did not
include zero for the cartilage thickness within the meniscal window of the lateral tibia (wLT$ThCtAB) at 6
month follow-up (1.5%, 95% CI [2.9, 0.2]), but was not signiﬁcant at the 5% level after correction for
multiple comparisons.avid John Hunter, Division of
Hill Ave, Boston, MA 02120,
D.J. Hunter).
s Research Society International. Published by Elsevier Ltd. All rights reserved.
D.J. Hunter et al. / Osteoarthritis and Cartilage 18 (2010) 677e683678Conclusions: The small inconsistent compartment changes, and the relatively high variabilities in carti-
lage thickness changes seen over time in this study, provide no additional conﬁdence for a 3- or 6-month
PoC study using a patient population selected on the basis of risk for rapid progression with the MRI
acquisition and analyses employed.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
One proposed osteoarthritis (OA) treatment goal is preservation
of the underlying joint structure. In an effort to shorten develop-
ment timelines, and minimize patient exposure to investigational
therapies, clinical trial brevity is paramount. As OA is typically
a very slowly progressive condition, one can optimize trial efﬁ-
ciency by ﬁnding more responsive endpoint/s and or stratifying the
study sample to further enhance efﬁciency.
At the time this study was conceived in 2006, consensus in the
literature suggested that changes in magnetic resonance imaging
(MRI) measures of cartilage morphology 1 year were of the order
of 4e6% in selected patient groups1e4. Recent studies have
demonstrated superior responsiveness in the central medial femur
than the medial tibia5,6. However these data sets did not evaluate
intervals shorter than 6 months, and thus it was not clear if
one could conduct “Proof of Concept” (PoC) studies over shorter
time intervals. The study sponsor had recently conducted
a 6-month follow-up in elderly, obese, female participants with
radiographic evidence of OA [KellgreneLawrence (K&L) grade 2 or
3] and current knee pain7. The compartmental cartilage volumes
analyzed in this 6-month study showed no signiﬁcant changes after
6 months. However, analysis of cartilage thickness changes within
smaller focal regions identiﬁed using three-dimensional (3D)
statistical shape modelling giving an Anatomically Corresponded
Regional Analysis of Cartilage (ACRAC) detected decrease in carti-
lage thickness within the trimmed central medial femoral region of
8.2%, with 95% conﬁdence interval (CI) (15.6%, 0.2%)7.
In addition to image analysis techniques, several methods of
stratifying populations to enrich for persons at greater risk of
medial tibio-femoral (TF) compartment progression have been
proposed. These include increased body mass index (BMI)8, an
increased level of type II collagen C-terminal degradation products
detected in the urine9, the presence of varus mal-alignment at the
TF joint10e14, the presence on MRI of sub-chondral bone marrow
lesions15 or meniscal abnormalities16.
The primary objective of this study was to investigate the
potential of central medial femoral cartilage thickness, measured
by optimal MRI sequences with advanced image analysis, as
a biomarker endpoint for future 3-month disease modiﬁcation PoC
studies. The secondary objective was to investigate the potential of
changes in cartilage thickness in any region over 3 or 6 months
measured by MRI as biomarker endpoints for an OA PoC study.Table I
Study timeline and interval between visits
Visit 1 Visit 2a Visit 2b Visit 3 Visit 4
Screening Baseline 1 week 3 months 6 monthsMaterials and methods
Study design
This was a multi-centre, non-randomized, observational cohort
(Level II) study to assess the utility ofMRI in detectingmorphological
changes in knee OA over 3 and 6months. One hundred and forty-one
participants were enrolled across four sites in the US. Following
screening assessments and conﬁrmation of eligibility against all but
the X-ray inclusion criteria at Visit 1, participants were scheduled to
attend Visit 2a and arrangements made for a ﬁxed-ﬂexion poster-
oanterior (PA) view knee X-ray to be obtained and centrally assessed.
At Visit 2a, following conﬁrmation of X-rayeligibility criteria from thecentral review, participants were accepted for follow-up and the
target knee joint selected. The initial baseline MRI scan of the target
knee was then arranged to take place within 3 days of Visit 2a.
Subsequently, participants were to be followed-up 1 week 2 days
(Visit 2b), three calendar months 7 days (Visit 3) and six calendar
months 7 days (Visit 4) later (see Table I).
After each scheduled visit, MRI scanning of the target knee was
to be performed within 3 days. The Visit 2b, three and four MRI
scans were stipulated to take place at the same time of day (2 h)
as the ﬁrst MRI scan at Visit 2a. Participants were to remain rested
for a minimum of 30 min prior to each MRI scan (i.e., seated in the
MRI clinic waiting room).
Eligibility criteria
We targeted recruitment at participants with medial TF OA and
varus mal-alignment of the knee. The inclusion criteria assessed at
Visit 1 included:
1. Female participants aged 50 years and above.
2. BMI of 25 kg/m2 or above.
3. Radiographic evidence (within the last 3 months) of TF OA
deﬁned as ﬁxed-ﬂexion PA radiographs of the target knee(s)
showing deﬁnite medial TF osteophytes (OARSI grades 1e3)
and joint space narrowing (JSN) (OARSI grades 1e2, medial
JSN lateral JSN), excluding participants with severe JSN
(OARSI grade 3 or bone on bone), as assessed by central reading
of the X-ray17.
4. Knee varus mal-alignment (2 according to anatomical
alignment), determined by central reading of the ﬁxed-ﬂexion
radiograph (PA view)18,19.
5. Symptomatic disease as deﬁned by the presence of “pain,
aching or stiffness in or around the knee on most days” for at
least 1 month during the past 12 months.
6. Current knee pain, deﬁned as knee pain, in either knee, in the
oneweek before Visit 1, for which the patient gives a score of at
least 3 on a 0e10 scale for global knee pain (where 0¼ no pain,
and 10¼worst pain imaginable).
Exclusion criteria assessed at Visit 1 included:
1. Diagnosis of secondary OA due to inﬂammatory joint disease,
Paget's disease of the bone, major dysplasias or congenital
abnormality, or current diagnosis of another form of arthritis in
addition to OA.
2. Insufﬁcient knee ﬂexion for standardized positioning in X-ray.
3. Any planned surgery within the next 6 months.
4. Intra-articular injections of hyaluronic acid or corticosteroids to
the knee or other invasive orthopaedic surgery in the last 6
months, or planned within the next 6 months.
5. Major surgery or signiﬁcant trauma within the last 3 months.
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the practical aspects of MRI scanning.
7. Risk (in the investigator's opinion) of transmitting HIV or
Hepatitis B.
8. Pregnancy.
9. Participation in another clinical study involving an investiga-
tional compound, the last follow-up visit of which was within
90 days of Visit 1 in this study.
10. Use of ambulatory aids, other than a single cane, for more than
50% of the time in ambulation.
11. Current use of Disease Modifying OA Drugs (DMOADs) (e.g.,
doxycycline, diacerin, glucosamine, chondroitin) unless on
dose which had been stable for at least 3 months prior to Visit
2, and which would remain stable during the study.Fig. 1. Regions of interest: nuclear (trimmed) central meniscal window regions on the
medial and LF (nwcMF & nwcLF).Plain radiographs
Participants were required to have a ﬁxed-ﬂexion knee X-ray
(PA view) to conﬁrm eligibility for this study. PA views were
obtained using a SynaFlexer frame (Synarc, Inc., San Francisco,
CA) to position the subject's feet reproducibly20.
X-ray images were assessed by a musculoskeletal radiologist to
evaluate for individual radiographic features of JSN, and osteophyte
grading according to the OARSI atlas17, K&L grade21, and anatomical
alignment. The anatomic axis was determined as the angle formed
by the intersection of two lines originating from points bisecting
the femur and tibia and converging at the centre of the tibial spine
tips (inter-condylar eminence), using three points to specify the
lines as previously described18.
MRI acquisition
MRI was performed on the index knee using Siemens 3 T Trio
systems using the same imaging sequences as used in the OA
Initiative (OAI)22. MR imaging centres conducted pre-study training
that included safety pre-screening, subject identiﬁcation coding,
loading of protocols into the MRI system, scanning, data transfer
and site archival procedures. Uniformity and Linearity (UAL) and
knee phantoms supplied by VirtualScopics (Rochester, NY) were
scanned and visually assessed for distortion, warping and double
shadowing along with protocol compliance. Further quality control
continued for the duration of the study.
MR image analysis
The MR images were transferred to Imorphics for analysis
using the Anatomically Corresponded Regional Analysis of Carti-
lage (ACRAC) technique23. Cartilage was segmented from the Dual
Echo Steady State water excitation (DESSwe) MR images by
a single trained operator (BW, acknowledged below) who was
blind to visit but not to patient. The segmenter had previously
segmented two full scale trials of OAI data, and had passed the
Imorphics training protocol, which requires segmenters to be able
to repeatedly segment the femoral, medial tibial, lateral tibial and
patella cartilage compartments an intra-observer coefﬁcient of
variation (CoV) of less than 3% using a set of paired images
blinded at random. The cartilage outline was identiﬁed on each
slice by manual tracing using Imorphics EndPoint software,
following the Imorphics segmentation protocol. For each patient,
the MR images were segmented in pairs, using the ﬁrst image
segmented as a reference for further segmentations. The ﬁrst
image to be segmented was allocated at random. The remaining
images were segmented in turn with the ﬁrst segmentation from
the patient for reference. All of the hyaline cartilage was identiﬁedin each slice of each image for the femoral, medial tibial, lateral
tibial and patellar cartilage.
Cartilage segmentations were reviewed by an expert segmenter
with 7 years experience of cartilage segmentation (MB) for
consistency. The reviewer was also blinded to visit but not to
patient. In the event that the expert segmenter was uncertain of
a reading, a musculoskeletal radiologist (CH) was consulted, and
the segmentation agreed.
3D cartilage surfaces were constructed from the planar contours
using shape interpolation between adjacent slices, utilizing a 3D
signed-distance function using information from each planar
contour. The 3D surfaces were reviewed visually against the orig-
inal image, and using 3D VRML visualization.
A statistical model was built from the DESSwe images of both
knees from the 160 participants initially released by the OAI as
group 0.B.1. The models were built using the piecewise afﬁne
registration method24 which takes the whole of the MRI image
around the knee for each member of the training set, and generates
a statistical model for the whole volume. During model construc-
tion, each member of the training set is populated with a dense
network of control points throughout the volume.
This model was used to generate a mean image of the 160
subjects, which was manually segmented by a musculoskeletal
radiologist (CH) to identify the bone surface of the femur, tibia and
patella. The articular cartilage and the menisci were also
segmented.
This segmentation was then used to create 3D surfaces for the
bone, meniscus and cartilage, which can then be projected to all
examples in the model, using the control points. In the femur over
30,000 points are ﬁtted to the bone surface e previous studies have
shown that when these points are propagated out to the examples
in the training set, they have mean positional errors of less than
1 mm25. This, therefore provides a dense, anatomical corresponded
set of points, which can be used to take measurements and identify
regions for any image to which the bone model is ﬁtted.
The tAB regions for the femur, tibia and patella were then
identiﬁed, deﬁned as the bone which is covered by cartilage within
the mean image. Similarly, the meniscal window on the tibia (w)
can be identiﬁed as the region on the bone surface which falls
within the menisci in the image.
On the tibia, the meniscal window is not subdivided, but on the
femur, we further divide the meniscal window into a central
section (c) and a posterior section (p). A line is drawn along the
bone which is directly beneath the posterior edge of the meniscus;
this line is extended smoothly both medially and laterally to the
edge of the tAB region. The central section is deﬁned as the area of
bone anterior to this line, and the posterior region is the windowed
region behind this (Fig. 2).
To consistently remove the cartilage edges, which are most
prone to noise and partial volume, a trimming boundary was
Fig. 2. Regions of interest: nuclear (trimmed) meniscal window regions (nwMF, nwLF,
nwMT, nwLT).
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mean bone model using an algorithm that progressively eroded the
tAB areas evenly from their edges. This was achieved by selecting
a new series of correspondence points with approximately the
same shape as the original region. Because the trimming boundary
is formed from a line drawn through correspondence points on the
model, the trimming boundary is propagated automatically to each
imagewhen themodel was ﬁtted. The trimming boundary that was
chosen for the femoral, medial and lateral tibial and patellar
cartilage plate reduced each of them by around 35%.
Each image in the study was then ﬁtted with the bone reference
surface from the model, thereby also identifying the tAB regions,
and the various anatomical regions described above.
The primary outcome variable was the overall mean cartilage
thickness (with areas denuded of cartilage included as having zero
thickness e ThCtAB26) within the aspect of the central (c) medial
femur (MF) condyle which is exposed within the meniscal window
(w) during articulation with the cartilage edges “trimmed” leaving
the nuclear (n) region as described above, with nomenclature
nwcMF.
The secondary variables were the overall mean cartilage thick-
ness (with denuded areas included as having zero thickness e
ThCtAB) across the following regions (see Figs. 1 and 2 for
examples)26:
(a) On the medial femur (seven regions): medial femur (MF),
central medial femur (cMF), medial femur meniscal window
(wMF), central medial femur meniscal window (wcMF),
nuclear (trimmed) medial femur (nMF), nuclear (trimmed)
central medial femur (ncMF), nuclear (trimmed) medial
femoral meniscal window (nwMF).
(b) On the medial tibia (four regions): medial tibia (MT), medial
tibial meniscal window (wMT), nuclear medial tibia (nMT),
nuclear medial tibial meniscal window (nwMT).
(c) Across the medial TF joint (four regions): central medial TF
(cMTF), central medial TF meniscal window (wcMTF), nuclear
central medial TF (ncMTF), nuclear central medial TF meniscal
window (nwcMTF).
(d) On the lateral femur (LF) (eight regions): LF, central LF (cLF),
lateral femur meniscal window (wLF), central lateral femur
meniscal window (wcLF), nuclear (trimmed) LF (nLF), nuclear
(trimmed) central LF (ncLF), nuclear (trimmed) lateral femur
meniscal window (nwLF), nuclear (trimmed) central lateral
femur meniscal window (nwcLF).
(e) On the lateral tibia (LT) (four regions): LT, lateral tibial meniscal
window (wLT), nuclear LT (nLT), nuclear lateral tibial meniscal
window (nwLT).
(f) Across the lateral TF (LTF) joint (four regions): central LTF
(cLTF), central LTF meniscal window (wcLTF), nuclear central
LTF (ncLTF), nuclear central LTF meniscal window (nwcLTF).Baseline MRI cartilage morphology measures
Two baseline MRI assessments were carried out a week apart
(2 days) at Visits 2a and 2b to assess the reproducibility of the
technique. The mean of the values from these two baseline
assessments or the single value (where only one value was avail-
able), referred to as “mean baseline”was used as the baseline value
from which change at 3 and 6 months was assessed. , The mean of
the two baseline values was calculated on the logarithmic scale for
analyzing proportional change and calculating changes as
a percentage of baseline, and is therefore the geometric mean on
the natural scale. The averaging of the two baseline scans can
reduce the variability, potentially yielding more accurate
measurements of change and thereby improving the power of the
analysis in comparison to using the value from only one of the Visit
two MRI assessments as baseline value.
Statistical analysis methods
The analysis set is the set of participants who completed Visit 2a,
had at least one follow-up visit (2b, 3 or 4), and were not subse-
quently withdrawn due to protocol violations.
The statistical analysis for the primary and secondary objective
was performed using an analysis of variance (ANOVA) model. Since
it is the rate of change in the primary variable at 3 months from
baseline, which is of primary interest, the ANOVA response variable
was the log transformed ratio of the 3 months to the baseline
measurement. The model included a ﬁxed factor for visit and
a baseline covariate for the (log transformed) cartilage thickness
value. The mean change and 95% CI were back-transformed for
presentation in terms of the percentage change from baseline,
along with the corresponding P-value.
Assumptions of normality were explored graphically through
normal probability plots for the residuals from ﬁtting this model. If
assessment of the model residuals for the primary variable sug-
gested that the model is a reasonable ﬁt to the data, then the same
model was to be used to analyze all the MRI cartilage morphology
variables. If not, a non-parametric technique or the actual change
from baseline was to be considered to validate the results of the
main analysis.
The level of agreement between the baseline values for the
primary variable was assessed across the patient group using the
statistical techniques of BlandeAltman for method comparison
studies27, i.e., by plotting the difference between the two baseline
measurements against the mean of the measurements and
including a reference range of 95% limits of agreement given by
d 1.96s where d is the mean difference and s is the standard
deviation of the difference between the two baseline measure-
ments. The baseline reproducibility of each variable was obtained
by ﬁtting an ANOVA model to the log transformed variable
including subject as a random effect. The inter-subject components
of variation on the log-scalewere obtained from the ANOVAmodels
and are presented back-transformed as CoV.
Results
One hundred and forty-one participants were enrolled across
four sites in the US. Omitting participants who were withdrawn
due to ineligibility, 30 participants completed Visit 2a and
continued in the study. Of these, one participant was lost to follow-
up after Visit 2a and had no further assessments. The remaining 29
had at least one follow-up visit.
Table II shows the baseline characteristics of the study sample.
The mean age was 62.2 years, with range 50e80 years. The mean
BMI was 35.9, with range 30.8e50.9. Two participants were black,
Table II
Baseline characteristics of study sample
Gender [female N (%)] 29 (100)
Age (mean, SD), years 62.1 (8.3)
BMI (mean, SD), kg/m2 35.9 (4.8)
Index knee [left N (%)] 14 (48)
WOMAC pain (mean, SD) (0e20 scale) 7.3 (2.6)
K&L grade of index knee, no. (%) Grade Number of knees
2 8 (28)
3 21 (72)
Anatomic axis (mean, SD), 0.91 (2.0)
Table III
Changes from mean baseline at 3 and 6 months in MRI cartilage thickness variables
Region Over 3 months Over 6 months
N % Change 95% CI N % Change 95% CI
nwcMF 27 2.1 (4.4, 0.2) 28 0.0 (2.7, 2.8)
nwMF 27 0.9 (2.1, 0.2) 28 1.1 (0.4, 2.6)
ncMF 27 1.3 (2.6, 0.1) 28 0.6 (1.3, 2.5)
nMF 27 0.8 (1.7, 0.1) 28 1.3 (0.1, 2.6)
wcMF 27 1.6 (3.7, 0.5) 28 0.4 (2.0, 2.8)
wMF 27 1.0 (2.5, 0.5) 28 1.2 (0.2, 2.7)
cMF 27 1.1 (2.6, 0.4) 28 0.6 (1.1, 2.3)
MF 27 1.1 (2.4, 0.1) 28 1.0 (0.6, 2.5)
nwMT 27 0.7 (2.3, 3.8) 28 1.2 (3.3, 1.0)
nMT 27 0.4 (2.1, 2.9) 28 0.5 (2.9, 2.0)
wMT 27 0.8 (2.0, 3.6) 28 1.0 (2.9, 0.9)
MT 27 0.3 (2.0, 2.8) 28 1.4 (3.5, 0.8)
nwcMTF 27 0.5 (2.2, 1.3) 28 0.4 (2.3, 1.6)
ncMTF 27 0.4 (1.7, 1.0) 28 0.2 (1.7, 2.0)
wcMTF 27 0.4 (2.0, 1.3) 28 0.1 (1.8, 1.6)
cMTF 27 0.4 (1.8, 1.0) 28 0.3 (1.9, 1.3)
nwcLF 27 0.1 (1.2, 0.9) 28 0.3 (0.8, 1.5)
nwLF 27 0.7 (0.5, 2.0) 28 0.3 (1.0, 1.5)
ncLF 27 0.1 (0.8, 1.1) 28 0.1 (1.3, 1.1)
nLF 27 0.8 (0.4, 2.0) 28 0.1 (1.5, 1.3)
wcLF 27 0.0 (1.1, 1.2) 28 0.4 (0.7, 1.5)
wLF 27 0.5 (0.8, 1.9) 28 0.2 (1.0, 1.5)
cLF 27 0.2 (1.1, 1.6) 28 0.3 (1.5, 0.9)
LF 27 0.7 (1.0, 2.4) 28 0.6 (1.9, 0.9)
nwLT 27 0.1 (2.0, 1.8) 28 1.2 (2.4, 0.1)
nLT 27 0.7 (0.4, 1.7) 28 0.6 (1.7, 0.5)
wLT 27 0.2 (2.3, 2.0) 28 1.5 (2.9, 0.2)
LT 27 1.1 (0.1, 2.3) 28 0.9 (2.3, 0.6)
nwcLTF 27 0.2 (1.2, 0.9) 28 0.1 (1.0, 0.7)
ncLTF 27 0.3 (0.5, 1.2) 28 0.3 (1.1, 0.5)
wcLTF 27 0.1 (1.2, 1.1) 28 0.2 (1.1, 0.6)
cLTF 27 0.6 (0.5, 1.8) 28 0.5 (1.4, 0.4)
The mean and 95% CI estimates are from ﬁtting ANOVA models to the log trans-
formed data.
The ANOVA models include the baseline measure as a covariate.
The baseline is the geometric mean of the value at Visits 2a and 2b.
CIs are not corrected for multiple comparisons.
Legend for regions as detailed in Materials and methods section.
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Fig. 3. Changes at 3 and 6 months in MRI cartilage thickness (ThCtAB) in
nuclear (trimmed) central meniscal windowed regions on the medial and LT and femur.
The mean and 95% CI l estimates are from ﬁtting ANOVA models to the log transformed
data. The ANOVA models include the baseline measure as a covariate. The baseline is
the geometric mean of the value at Visits 2a and 2b. CIs are not corrected for multiple
comparisons. The baseline CoV overlaid is the within-subject.
D.J. Hunter et al. / Osteoarthritis and Cartilage 18 (2010) 677e683 681the remaining 27 were white. Eight subjects had a K&L grade of 2,
the remaining 21 had a grade of 3. Anatomical alignment ranged
from 1.92 to 6.27, with mean 0.91, where varus mal-alignment
is measured in the positive direction.
Twenty-seven of the 29 participants in the overall analysis set
had overall mean cartilage thickness (with areas denuded of
cartilage included as having zero thickness) (ThCtAB) within the
aspect of central medial femoral condyle exposed within the
meniscal window during articulation with cartilage edges “trim-
med” (nwcMF) measured from MRI scans of sufﬁcient quality at
least one baseline visit (Visit 2a or Visit 2b) and at the 3-month
follow-up visit (Visit 3) and were included in the analysis. The ﬁnal
analysis sets for the MRI objectives consisted of 28 subjects for
objectives not involving the 3-month time-point, with one less (27)
subjects for the assessment of 3-month change and linearity.
The change in the primary variable (nwcMF$ThCtAB) from
(mean) baseline at 3 months from the log-scale ANOVA model was
2.1%, 95% CI (4.4%, þ0.2%). The change over 6 months was 0.0%
(95% CI l (2.7%, þ2.8%)).
Changes in the primary and secondary MRI cartilage thickness
variables over 3 and 6 months from (mean) baseline calculated
from the ANOVA model are tabulated in Table III. Results for the
nuclear (trimmed) central meniscal windowed regions on the
medial and LT and femur (nwcMF, nwMT, nwcLF, nwLT) are plotted
in Fig. 3. The 95% CI for the change from baseline did not include
zero for the cartilage thickness within the meniscal window of the
LT over 6 months [1.5%, 95% CI (2.9, 0.2)]. With that exception,
no signiﬁcant changes in cartilage thickness were detected at the
5% level for any of the regions of interest on the TF joint over 3 or 6
months in this study.
Twenty-eight of the 29participants in the overall analysis set had
the primaryMRI cartilagemorphology variable measured fromMRI
scans of sufﬁcient quality at both baseline visits (Visit 2a and Visit
2b) and were included in the analysis of baseline reproducibility.
The BlandeAltman plots for the primary variable nwcMF$ThCtAB
atVisits 2a and2bshow limits of agreementbetween the twobaseline
visits of approximately 0.13 mm (Fig. 4). However, the mean carti-
lage thickness over this region for all 28 subjects is only 1.5 mm at the
baseline visits, and calculated on the log-scale the limits of agreement
as percentages are (15%, 17%) (Fig. 5).
The repeatability of the measurement of cartilage thickness was
typically around 2% measured as CoV (RMS). This compares well
with other studies28 and indicates that the measurement noise in
this study is at least as small as published work (Table IV). The
repeatability of the bone area tAB is provided in the second column.
This shows the repeatability of the bone search, and it's ability to
automatically identify a propagated region. The repeatability of the
bone search is considerably better than that of the cartilage thick-
ness. It is notable that the repeatability of the primary region
nwcMF has the poorest repeatability (though still comparable with
other authors). This may be caused by the presence of denuded
cartilage in this region, which is usually the source of increased
noise in cartilage measurement.Discussion
With one exception (lateral tibial meniscal window), no signif-
icant changes in cartilage thickness were detected at the 5% level
for any of the regions of interest on the TF joint over 3 or 6 months
in this study. However, the changes in 32 primary and secondary
Fig. 4. BlandeAltman plot showing the agreement between the Visit 2a and Visit 2b
values of the primary variable nwcMF$ThCtAB.
Table IV
Measurement repeatability for thickness and bone area: repeatability is shown for
the difference in measurements between the Visit 2a and 2b images
ACRAC region ThCtAB tAB
CoV (%) CoV (%)
MF 2.2 1.3
nwcMF 5.7 1.2
MT 2.5 0.8
nwMT 2.3 1.5
LF 2.8 1.9
LT 3 1.7
D.J. Hunter et al. / Osteoarthritis and Cartilage 18 (2010) 677e683682MRI cartilage morphology variables were tested at 3 and 6 months,
without consideration of the multiplicity of statistical comparisons,
so this single signiﬁcant (uncorrected) change should be inter-
preted with caution.
Baseline testeretest variabilities were low, and are
comparable with other published MRI cartilage morphology
reproducibilities5,14,29e32, but were often higher than the average
change seen over 3 and 6 months. The changes seen in this study
are consistent with those reported over 12 months in similar
cohorts from the OAI incidence group5,6.
Prior studies using a sub-regional approach have found the
greatest changes are in the central weight bearing portions of the
medial TF joint-hence the reason we focused our attention here.
The study by Pelletier et al. found the greatest change in the central
medial tibia followed by central medial femur2. Similarly Wirth
et al. found that rate of cartilage loss was greater in central sub-
regions than in entire FT cartilage plates.
Power calculations were performed to estimate the overall
sample size required for a parallel group design to have 80% power
to detect a complete halting of cartilage thinning (0% change) in
a treatment group in comparison with a placebo group exhibiting
the thinning shown in this study, where the change in both groups
has the variability observed in this study, for a 10% signiﬁcance level
analyzed using a t test to compare the changes between groups,
and allowing for a 10% drop-out. For the primary variable
(nwcMF$ThCtAB) over 3 months using a repeat mean baseline
(where a change of 2.0% from mean baseline was observed with
a variability of 7.14% in this study) an overall sample size of 353Fig. 5. BlandeAltman plot (calculated on the log-scale) showing agreement between
the Visit 2a and Visit 2b values of the primary variable nwcMF$ThCtAB in terms of
percentage change.would be required. For the primary variable (nwcMF$ThCtAB) over
3 months using a single-baseline (where a change of 2.5% from
ﬁrst baseline was observed with a variability of 6.46% in this study)
an overall sample size of 187 would be required. If the treatment
group had less effect than the complete halting proposed here the
sample sizes would be even larger.
However, given the lack of conﬁdence in the mean changes
observed due to the relatively high variabilities, in particular the
fact that the mean changes in cartilage thickness are not signiﬁ-
cantly different from zero, power calculations based on the point
estimates of the changes and variabilities observed in this study
should be treated with extreme caution. The apparent improved
power with single-baseline as opposed to double baseline maywell
be spurious. The actual sample size required for a 3-month study
may be much greater. Indeed, from these data the possibility that
there is no overall change in cartilage thickness during the ﬁrst 3
months of such a study cannot be ruled out.
There are a number of limitations of this study. The size of the
study sample investigated was small and could have contributed to
the lack of meaningful and consistent change at both 3 and 6
months. There is the possibility that methods other than those
based on the analysis of anatomical sub-regions may have provided
better discrimination of subjects.
Taken alone, this study gives no conﬁdence that measures of
cartilage thickness obtained using the MR image acquisition and
analysis deployed in this study provide a viable biomarker endpoint
for future 3- or 6-month disease modiﬁcation PoC studies in
a highly stratiﬁed sample. Therefore cartilage thickness measured
using MRI should not be considered as a biomarker for 3-month
follow-up studies of OA without compelling additional data. Six-
month follow-up studies may be possible, but given this study and
currently available data this strategy should be considered high
risk. Finally, this is an active area of research, and future develop-
ments in image acquisition, analysis and patient selection may yet
yield viable imaging biomarkers for short, small PoC studies.
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